Download Pharmacy Curriculum Draft (NCRC); 2011
Download Pharmacy Curriculum Draft (NCRC); 2011 Download Pharmacy Curriculum Draft (NCRC); 2011
a. Introduction to Biotechnology: Genetics/Genomics, Proteomics, Biomoleculartarget Identification, Pharmacogenomics, Gene therapy and Nucleic acidtherapeutics.b. Techniques used in Pharmaceutical biotechnology: PCR, DNA Sequencing,Affinity Protein Purification.c. Fundamentals of Genetic Engineering and its Application in Medicined. Pharmaceutical Recombinant therapeutic Proteins, Growth factors,Therapeutic antibodies, High-throughput screening of putative therapeuticcompounds.e. Biotechnological aspects in the product developmentf. Principle, Synthesis and Application of Monoclonal Antibodiesg. Immobilized Enzymes and their application in MedicinePHARM 721 PHARMACEUTICS-XIV (Pharmaceutical Technology-II)[Lab.]Cr. Hr.: 01 Marks: 50NOTE:- Practical of the subject shall be designed from time to time on the basis ofthe above mentioned theoretical topics and availability of the requirements, e.g.Various techniques to develop the formulation, Granulation technology, Study ofdrug delivery systems, Biotechnological aspect of product development, In-vitroQuality Control of various dosage forms. Microbial assay, Particle size analysisusing various methods, Stability studies of Pharmaceuticals, Coating of particlesand To prepare, examine and control specifications of packaging materials.Recommended Books:1. Anya M. Hellery, Drug delivery and targeting, 13 th Ed,Taylor & Francis,London, 2001.2. Joseph R Robinson Controlled drug delivery, Marcel & Dakker Inc, New York,2ndEd., 1992.3. T V Ramabhadran, Pharmaceutical design and development, Ellis Horwood,New York, 1994.4. M E Aulton, Pharmaceutics: Science of Dosage Forms Design, ELBS/ChurchillLivingstone, London, 1998.5. Banker, Modern pharmaceutics, Marchell Dakker Inc, New York, 2002.6. John A Bontempo, Development of biopharmaceutical parenteral dosageforms, Marchell Dakker Inc, New York, 1997.7. N K Jain, Controlled and Novel drug delivery, CBS Publishers & Distributers,New Delhi, 2004.8. Ansel, Pharmaceutical Dosage Form in Drug Delivery System, Lee & Febiger,London,2004.9. Attaurahman and M I Chaudry, Bioassay techniques for drug development,CRC Press, LLC, USA, 2001.86 | Pakistan Pharmacist Federation; www.pharmacistfed.pk,www.pharmafed.wordpress.com, www.pharmarev.com, info@pharmacistfed.pk,
PHARM 722 PHARMACY PRACTICE-XIII (ClinicalPharmacy-IV) [Th.]Cr. Hr.: 03 Marks: 1001. PHARMACEUTICAL CARE, ITS SCOPE, MANAGEMENTANDAPPLICATION OF CARE PLAN2. CLINICAL THERAPEUTICS:(a) General Strategy: Terminology of Disease. Management and Treatment. DrugSelection.(b) Basic introduction of some clinical situations, their clinical features, etiology,pathophysiology and treatment of causes: Common Cold, Pharyngitis andTonsillitis, Pneumonia, Tuberculosis, Diarrhea (Amoebic & BacillaryDysentery, Giardiasis) Malaria, Meningitis, Tetanus, Typhoid Fever, Measles,Rabies, AIDS, Congestive cardiac failure, Conjunctivitis, Anemia, Gout,Asthma, Ulcer, Diabetes mellitus, Hypertension, Hepatitis, Dermatology(Scabies, Fungal diseases), Dengue fever.3. CLINICAL TOXICOLOGY:(a) General information. Role of pharmacist in treatment of poisoning and generalmanagement of poisoning & over dosage. Role and Status of Poison ControlCentre.(b) Antidotes and their mechanism of action.4. SAFE INTRAVENOUS THERAPY & HAZARDS OF IV THERAPY5. NON-COMPLIANCE: Definition, introduction and importance, Extent of noncompliance,Methods of assessment, Reasons for non-compliance, Strategies forimproving compliance and Designing of compliance trials.PHARM 723 PHARMACY PRACTICE-XIII (ClinicalPharmacy-IV) [Lab.]Cr. Hr.: 01 Marks: 50• Clerkship in the Clinical Setting. A project related to Clinical Pharmacy Practiceswill be completed by the students and will be evaluated by the external examiner.• Student are required to take/present verbal presentation, communication, writtenand problem-solving skills, critical analysis of data and provision of care through aweekly conference and projectsRecommended Books:1. Roger Walker, Clinical Pharmacy & Therapeutics, Churchill Levingstone,London, 4th, 2003.2. Guard Paul, A Behavioral Approach to Pharmacy Practice, Black Well, USA,2000.3. Herfindal Gourley, Clinical Pharmacy & Therapeutics, 4 th Ed,William &Willkins, London, 1992.4. A J Winfield, Pharmaceutical Practice, Churchill Levingstone, London, 3 rd Ed.,2003.87 | Pakistan Pharmacist Federation; www.pharmacistfed.pk,www.pharmafed.wordpress.com, www.pharmarev.com, info@pharmacistfed.pk,
- Page 35 and 36: e. Drug treatment of chronic inflam
- Page 37 and 38: j. Labiatae Peppermint, Thyme, Spea
- Page 39 and 40: SECOND SEMESTERPS 403PAKISTAN STUDI
- Page 41 and 42: NOTE:- Practicals of the subject sh
- Page 43 and 44: i. Drugs used for cough (Anti-tussi
- Page 45 and 46: 1. Drugs of Animal OriginGeneral in
- Page 47 and 48: Frequency Table, Diagrams, Pictogra
- Page 49 and 50: pharmaceutical students Churchill L
- Page 51 and 52: anaesthetic drugs on human and the
- Page 53 and 54: 5. Plant SteroidsIntroduction, extr
- Page 55 and 56: Adenoma, Chondroma, Fibroma, Leomyo
- Page 57 and 58: Aluminium Hydroxide, Ammonium Chlor
- Page 59 and 60: of frog. To demonstrate the effects
- Page 61 and 62: 6. Tumor Inhibitors from PlantsIntr
- Page 63 and 64: • Components of a Computer• Com
- Page 65 and 66: 1. INTRODUCTION(a) Role of Pharmaci
- Page 67 and 68: withdrawal, Detection, Management o
- Page 69 and 70: (Note: A minimum of 10 practicals w
- Page 71 and 72: 14. Ronald D Schoenwald, Pharmacoki
- Page 73 and 74: Distribution, Relationship between
- Page 75 and 76: 4. A J Winfield, Pharmaceutical Pra
- Page 77 and 78: . Factors: persistent, accumulation
- Page 79 and 80: vaccines.5. MISCELLANEOUS DETERMINA
- Page 81 and 82: 3. T V Ramabhadran, Pharmaceutical
- Page 83 and 84: 1. R Z Hussain, The Manual of Drug
- Page 85: NOTE:- Practical of the subject sha
- Page 89 and 90: 3. The Pharmacy Act 1967.4. The Poi
- Page 91 and 92: 6. Block, Roche, Soine and Wilson.
- Page 93 and 94: PHARM-D FIVE-YEAR COURSESCHEME OF S
- Page 95 and 96: Paper 4 Pharmacy Practice -VI (Fore
- Page 97 and 98: 9. PREPARATION AND PROPERTIES OF HE
- Page 99 and 100: c. Proteins and Amino acids: Brief
- Page 101 and 102: 3. PHYSICO-CHEMICAL PRINCIPLES:a. S
- Page 103 and 104: 2. Cooper and Gunns Tutorial Pharma
- Page 105 and 106: Experiences, Motivation and Emotion
- Page 107 and 108: 5. CENTRAL NERVOUS SYSTEM: Nerve Mu
- Page 109 and 110: (b)Spinal Cord — Meninges (C.S.F.
- Page 111 and 112: 1. DESCRIPTION OF STATISTICS: Descr
- Page 113 and 114: Part: B, (Communications Skills)Obj
- Page 115 and 116: 1. Writing. Advanced by Ron White.
- Page 117 and 118: effervescent, granulated salts. Har
- Page 119 and 120: Parasympathetic antagonists.f. Gang
- Page 121 and 122: (Note: A minimum of 20 practicals w
- Page 123 and 124: Sources, structure, preparation, de
- Page 125 and 126: Microbiology with special reference
- Page 127 and 128: Objectives• Develop vision of his
- Page 129 and 130: 2 To enhance understanding of the s
- Page 131 and 132: 1) Basic Concepts of Islam & Scienc
- Page 133 and 134: Chondroma, Fibroma, Leomyoma, Neofi
- Page 135 and 136: Note:(a)(b)(c)(d)Pollution and its
PHARM 722 PHARMACY PRACTICE-XIII (Clinical<strong>Pharmacy</strong>-IV) [Th.]Cr. Hr.: 03 Marks: 1001. PHARMACEUTICAL CARE, ITS SCOPE, MANAGEMENTANDAPPLICATION OF CARE PLAN2. CLINICAL THERAPEUTICS:(a) General Strategy: Terminology of Disease. Management and Treatment. DrugSelection.(b) Basic introduction of some clinical situations, their clinical features, etiology,pathophysiology and treatment of causes: Common Cold, Pharyngitis andTonsillitis, Pneumonia, Tuberculosis, Diarrhea (Amoebic & BacillaryDysentery, Giardiasis) Malaria, Meningitis, Tetanus, Typhoid Fever, Measles,Rabies, AIDS, Congestive cardiac failure, Conjunctivitis, Anemia, Gout,Asthma, Ulcer, Diabetes mellitus, Hypertension, Hepatitis, Dermatology(Scabies, Fungal diseases), Dengue fever.3. CLINICAL TOXICOLOGY:(a) General information. Role of pharmacist in treatment of poisoning and generalmanagement of poisoning & over dosage. Role and Status of Poison ControlCentre.(b) Antidotes and their mechanism of action.4. SAFE INTRAVENOUS THERAPY & HAZARDS OF IV THERAPY5. NON-COMPLIANCE: Definition, introduction and importance, Extent of noncompliance,Methods of assessment, Reasons for non-compliance, Strategies forimproving compliance and Designing of compliance trials.PHARM 723 PHARMACY PRACTICE-XIII (Clinical<strong>Pharmacy</strong>-IV) [Lab.]Cr. Hr.: 01 Marks: 50• Clerkship in the Clinical Setting. A project related to Clinical <strong>Pharmacy</strong> Practiceswill be completed by the students and will be evaluated by the external examiner.• Student are required to take/present verbal presentation, communication, writtenand problem-solving skills, critical analysis of data and provision of care through aweekly conference and projectsRecommended Books:1. Roger Walker, Clinical <strong>Pharmacy</strong> & Therapeutics, Churchill Levingstone,London, 4th, 2003.2. Guard Paul, A Behavioral Approach to <strong>Pharmacy</strong> Practice, Black Well, USA,2000.3. Herfindal Gourley, Clinical <strong>Pharmacy</strong> & Therapeutics, 4 th Ed,William &Willkins, London, 1992.4. A J Winfield, Pharmaceutical Practice, Churchill Levingstone, London, 3 rd Ed.,2003.87 | Pakistan Pharmacist Federation; www.pharmacistfed.pk,www.pharmafed.wordpress.com, www.pharmarev.com, info@pharmacistfed.pk,
Change language